Viewing Study NCT07180160


Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2025-12-26 @ 2:29 AM
Study NCT ID: NCT07180160
Status: RECRUITING
Last Update Posted: 2025-11-18
First Post: 2025-09-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Iparomlimab and Tuvonralimab (QL1706) in Patients With HR-positive, HER2-negative Advanced Breast Cancer
Sponsor: Wenjin Yin
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module